COLOMBO, NICOLETTA
COLOMBO, NICOLETTA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2024 Oaknin, A; Gladieff, L; Martínez-García, J; Villacampa, G; Takekuma, M; De Giorgi, U; Lindemann, K; Woelber, L; Colombo, N; Duska, L; Leary, A; Godoy-Ortiz, A; Nishio, S; Angelergues, A; Rubio, M; Fariñas-Madrid, L; Yamaguchi, S; Lorusso, D; Ray-Coquard, I; Manso, L; Joly, F; Alarcón, J; Follana, P; Romero, I; Lebreton, C; Pérez-Fidalgo, J; Yunokawa, M; Dahlstrand, H; D'Hondt, V; Randall, L
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
2024 Colombo, N; Lorusso, D; Monk, B; Slomovitz, B; Hasegawa, K; Nogueira-Rodrigues, A; Zale, M; Okpara, C; Barresi, G; Mckenzie, J; Makker, V
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
2024 Boidot, R; Blum, M; Wissler, M; Gottin, C; Ruzicka, J; Chevrier, S; Delhomme, T; Audoux, J; Jeanniard, A; Just, P; Harter, P; Pignata, S; Gonzalez-Martin, A; Marth, C; Maenpaa, J; Colombo, N; Vergote, I; Fujiwara, K; Duforet-Frebourg, N; Bertrand, D; Philippe, N; Ray-Coquard, I; Pujade-Lauraine, E
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma
2024 Gambella, M; Carlomagno, S; Mangerini, R; Colombo, N; Parodi, A; Ghiggi, C; Giannoni, L; Coviello, E; Setti, C; Luchetti, S; Serio, A; Laudisi, A; Passannante, M; Bo, A; Tedone, E; Sivori, S; Angelucci, E; Raiola, A
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
2024 Ledermann, J; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, A; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; Mccluggage, W; Mcneish, I; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, J; Pignata, S; Ramirez, P; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, D; Taskiran, C; van Driel, W; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention
2024 Falanga, A; Lorusso, D; Colombo, N; Cormio, G; Cosmi, B; Scandurra, G; Zanagnolo, V; Marietta, M
Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study
2024 De Vitis, L; Fumagalli, D; Schivardi, G; Capasso, I; Grcevich, L; Multinu, F; Cucinella, G; Occhiali, T; Betella, I; Guillot, B; Pappalettera, G; Shahi, M; Fought, A; Mcgree, M; Reynolds, E; Colombo, N; Zanagnolo, V; Aletti, G; Langstraat, C; Mariani, A; Glaser, G
Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?
2024 Betella, I; De Vitis, L; Calidona, C; Multinu, F; Colombo, N
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
2024 Schouten, P; Schmidt, S; Becker, K; Thiele, H; Nürnberg, P; Richters, L; Ernst, C; Treilleux, I; Medioni, J; Heitz, F; Pisano, C; Garcia, Y; Petru, E; Hietanen, S; Colombo, N; Vergote, I; Nagao, S; Linn, S; Pujade-Lauraine, E; Ray-Coquard, I; Harter, P; Hahnen, E; Schmutzler, R
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial
2024 Tewari, K; Colombo, N; Monk, B; Dubot, C; Caceres, M; Hasegawa, K; Shapira-Frommer, R; Salman, P; Yanez, E; Gumus, M; de Mendoza, M; Samouelian, V; Castonguay, V; Arkhipov, A; Tekin, C; Li, K; Toker, S; Keefe, S; Lorusso, D
Photocatalytic Radical Coupling of Organoborates with α-Halogenated Electron-Poor Olefins
2024 Caldarelli, M; Rezzi, S; Colombo, N; Pirali, T; Papeo, G
Reply to P.-H. Luo et al
2024 Monk, B; Colombo, N; Tewari, K; Tekin, C; Keefe, S; Lorusso, D
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey
2024 Mongelli, M; Lorusso, D; Zanagnolo, V; Pignata, S; Colombo, N; Cormio, G
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence
2023 Plett, H; Ricciardi, E; Vacaru, V; Ramspott, J; Colombo, N; Sehouli, J; du Bois, A; Garbi, A; Richter, R; Ataseven, B; Aletti, G; Braicu, E; Heitz, F; Portuesi, R; Muallem, M; Dagres, T; Parma, G; Roser, E; Traut, A; Multinu, F; Harter, P
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial
2023 Schram, A; Colombo, N; Arrowsmith, E; Narayan, V; Yonemori, K; Scambia, G; Zelnak, A; Bauer, T; Jin, N; Ulahannan, S; Colleoni, M; Aftimos, P; Donoghue, M; Rosen, E; Rudneva, V; Telli, M; Domchek, S; Galsky, M; Hoyle, M; Chappey, C; Stewart, R; Blake-Haskins, J; Yap, T
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
2023 Pignata, S; Scambia, G; Schettino, C; Arenare, L; Pisano, C; Lombardi, D; De Giorgi, U; Andreetta, C; Cinieri, S; De Angelis, C; Priolo, D; Casanova, C; Rosati, M; Greco, F; Zafarana, E; Schiavetto, I; Mammoliti, S; Cecere, S; Salutari, V; Scalone, S; Farolfi, A; Di Napoli, M; Lorusso, D; Gargiulo, P; Califano, D; Russo, D; Spina, A; De Cecio, R; Chiodini, P; Perrone, F; Accinno, V; Altavilla, C; Antonelli, G; Artioli, G; Avola, F; Barbara, B; Barbato, V; Bartoletti, M; Bevilacqua, S; Bordonaro, R; Borghese, O; Buonfanti, G; Camarda, F; Canzanella, G; Carbone, V; Carbone, M; Carlo Stella, G; Cassani, C; Castagna, F; Cattaneo, M; Cinefra, M; Colombo, N; Corsetti, S; Dall'Agata, M; D'Amico, M; Daniele, G; De Marino, E; De Matteis, G; De Placido, S; Del Bene, G; Del Giudice, A; Del Monte, F; Del Sesto, M; Donini, M; Drudi, G; Falcone, G; Favaretto, A; Ferrera, G; Florio, M; Forestieri, V; Gallo, M; Gallo, C; Garibaldi, F; Gerevini, F; Ghizzoni, V; Giganti, M; Gimigliano, A; Giudice, E; Gnocchi, N; Gravina, A; Greggi, S; Iaia, M; Ilardi, A; Iovine, G; Ippoliti, G; Irollo, G; Isidori, I; Lapresa, M; Lavenia, G; Longhitano, L; Lucia, B; Luzi, G; Mariano, S; Marino, V; Marrapese, G; Martino, M; Matocci, R; Mazzoni, E; Mercuri, D; Mirto, M
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
2023 Colombo, N; Gadducci, A; Landoni, F; Lorusso, D; Sabbatini, R; Artioli, G; Berardi, R; Ceccherini, R; Cecere, S; Cormio, G; De Angelis, C; Legge, F; Lissoni, A; Mammoliti, S; Mangili, G; Naglieri, E; Petrella, M; Ricciardi, G; Ronzino, G; Salutari, V; Sambataro, D; Savarese, A; Scandurra, G; Tasca, G; Tomao, F; Valabrega, G; Zavallone, L; Pignata, S
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
2023 Willing, E; Vollbrecht, C; Vössing, C; Weist, P; Schallenberg, S; Herbst, J; Schatz, S; Jóri, B; Bataillon, G; Harter, P; Salutari, V; Martin, A; Vergote, I; Colombo, N; Roeper, J; Berg, T; Berger, R; Kah, B; Noettrup, T; Falk, M; Arndt, K; Polten, A; Ray-Coquard, I; Selzam, F; Pirngruber, J; Schmidt, S; Hummel, M; Tiemann, M; Horst, D; Sehouli, J; Pujade-Lauraine, E; Tiemann, K; Braicu, E; Heukamp, L
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial
2023 Sabatier, R; Rousseau, F; Joly, F; Cropet, C; Montegut, C; Frindte, J; Cinieri, S; Guerra Alia, E; Polterauer, S; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Largillier, R; Canzler, U; Gratet, A; Marme, F; Favier, L; Pujade-Lauraine, E; Ray-Coquard, I
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Matulonis, U; Lorusso, D; Oaknin, A; Pignata, S; Dean, A; Denys, H; Colombo, N; Van Gorp, T; Konner, J; Marin, M; Harter, P; Murphy, C; Wang, J; Noble, E; Esteves, B; Method, M; Coleman, R